Tempest Therapeutics Inc (TPST)
US$ 7.76-3.6%
Price Chart
Key Statistics
Market Cap
$ 27.58M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
22.91K
52W High
$ 28.34
52W Low
$ 5.35
Dividend Yield
0.00%
Beta
-2.30
Technicals
50-Day MA
6.9933
200-Day MA
9.7819
52 Week High
28.34
52 Week Low
5.3495
About TPST
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.
Employees
24
Headquarters
Brisbane, CA
CEO
Mr. Stephen R. Brady J.D., LLM
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg